Magnesium ions facilitate integrin alpha 2- and alpha 3-mediated proliferation and enhance alkaline phosphatase expression and activity in hBMSCs

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 10, 2016, Pages E527-E536

  Leem, Yea Hyun ^a   Lee, Kang Sik ^b   Kim, Jung Hwa ^b   Seok, Hyun Kwang ^c   Chang, Jae Suk ^b   Lee, Dong Ho ^b  

^a Dankook University   (South Korea)

^b Asan Medical Center   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

alkaline phosphatase; biomaterial; integrin; magnesium; osteocalcin; RUNX2

Indexed keywords

BIODEGRADABILITY; BIOMATERIALS; BONE; CELL ADHESION; COPYRIGHTS; GENE EXPRESSION; GLYCOPROTEINS; MAGNESIUM ALLOYS; PHOSPHATASES;

ALKALINE PHOSPHATASE; BONE IMPLANT; GENE ACTIVITIES; GENES EXPRESSION; HUMAN BONE MARROW DERIVED STROMAL CELLS; INTEGRINS; MAGNESIUM IONS; MAGNESIUM METAL; OSTEOCALCIN; RUNX2;

METAL IONS;

ALKALINE PHOSPHATASE; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; BETA1 INTEGRIN; MAGNESIUM CHLORIDE; MAGNESIUM ION; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; ARTICLE; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 85027946369     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1861     Document Type: Article

References (34)

1. Abboud CN, Scully SP, Lichtman AH, et al. 1985; The requirements for ionized calcium and magnesium in lymphocyte proliferation. J Cell Physiol 122: 64–72.
2. Albelda SM, Buck CA. 1990; Integrins and other cell adhesion molecules. FASEB J 4: 2868–2880.
3. Chapin RE, Adams J, Boekelheide K, et al. 2008; NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 83: 157–395.
4. Cowan JA. 2002; Structural and catalytic chemistry of magnesium-dependent enzymes. Biometals 15: 225–235.
5. Damsky CH. 1999; Extracellular matrix–integrin interactions in osteoblast function and tissue remodeling. Bone 25: 95–96.
6. Disthabanchong S, Radinahamed P, Stitchantrakul W, et al. 2007; Chronic metabolic acidosis osteoblast differentiation from human mesenchymal stem cells. Kidney Int 71: 201–209.
7. Gronowicz G, McCarthy MB. 1996; Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 14: 878–887.
8. Hartwig A. 2001; Role of magnesium in genomic stability. Mutat Res 475: 113–121.
9. Huang Y, Jin X, Zhang X, et al. 2009; In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 30: 5041–5048.
10. Hynes RO. 1992; Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25.
11. Iskandar ME, Aslani A, Liu H. 2013; The effects of nanostructured hydroxyapatite coating on the biodegradation and cytocompatibility of magnesium implants. J Biomed Mater Res Part A 101(8): 23040–23054.
12. Marie PJ, Hott M, Modrowski D, et al. 1993; An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8: 607–615.
13. Mazur A, Maier JA, Rock E, et al. 2007; Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458: 48–56.
14. Meunier OJ, Roux C, Seeman E, et al. 2004; The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350: 459–468.
15. Pittenger MF, Mackay AM, Beck SC, et al. 1999, Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
16. Reginster JY, Seeman E, De Vernejoul MC, et al. 2005; Strontium ranelate reduces the risk of nonvertebral fracture in women with osteoporosis: treatment of peripheral osteoporosis study. J Clin Endocrinol Metab 90: 2816–2822.
17. Rubin H. 2005, Magnesium: the missing element in molecular views of cell proliferation control. Bioassays 27: 311–320.
18. Rude RK, Gruber HE. 2004, Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 15: 710–716.
19. Rude RK, Oldhan SB, Singer FR. 1976; Functional hypoparathyroidism and parathyroid hormone and organ resistance in human Mg deficiency. Clin Endocrinol 5: 209–224.
20. Saito T, Albelda SM, Brighton CT. 1994; Identification of integrin receptors on cultured human cells. J Orthopaed Res 12: 384–394.
21. Seeman E, Vellas B, Benhamou C, et al. 2006; Strontium ranelate reduces the risk of vertebral and nonvertebral fracture in women eighty years of age and older. J Bone Miner Res 21: 113–120.
22. Serre CM, Papillard M, Chavassieux P, et al. 1998; Influence of magnesium substitution on collagen-apatite biomaterial on the production of a calcifying matrix by human osteoblasts. J Biomed Mater Res 42: 626–633.
23. Service RF. 2000; Tissue engineers build new bone. Science 289: 1498–1500.
24. Shimaya M, Muneta T, Ichinose S, et al. 2010; Magnesium enhances adherence and cartilage formation of synovial mesenchymal stem cells through integrins. Osteoarthritis Cartilage 18: 1300–1309.
25. Sun H, Wu C, Dai K, et al. 2006; Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials 27: 5651–5657.
26. Takaoka S, Yamaguchi S, Yano M, et al. 2010; The calcium-sensing receptor (CaR) in involved in strontium ranelate-induced osteoblast differentiation and mineralization. Horm Metab Res 42: 627–631.
27. Uhthoff HK, Poitras P, Backman DS. 2006; Internal plate fixation of fractures. Short history and recent developments. J Orthop Sci 11: 118–126.
28. Van der Flier A, Sonnenberg A. 2001; Structural and functional aspects of filamins. Biochim Biophys Acta 1538: 99–117.
29. Vormann J. 2003; Magnesium: nutrition and metabolism. Mol Aspects Med 24: 27–37.
30. Witte F, Kaese V, Haferkamp H, et al. 2005; In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials 26: 3557–3563.
31. Witte F, Ulrich H, Palm C, et al. 2007; Biodegradable magnesium scaffols. II. Peri-implant bone remodeling. J Biomed Mater Res A 81: 757–765.
32. Wolf FI, Trapani V. 2008; Cell (patho)physiology of magnesium. Clin Sci (Lond) 114: 27–35.
33. 2+-ion catalysis and substrate specificity. Mol Cell 22: 5–13.
34. Zreiqat H, Howlett CR, Zannettino A, et al. 2002; Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 62: 175–184.